CLINICAL OUTCOMES OF BORTEZOMIB-BASED THERAPY IN MYELOMA
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes
LONG-TERM OUTCOMES OF IMATINIB TREATMENTFOR
CHRONIC MYELOID
© 2022